Abstract

Cholera toxin subunit B (CTB) and Fluorogold(FG) are two widely utilized retrograde tracers to assess the number and function of retinal ganglion cells (RGCs). However, the relative advantages and disadvantages of these tracers remain unclear, which may lead to their inappropriate application. In this study, we compared these tracers by separately injecting the tracer into the superior Colliculi (SC) in rats, one or 2 weeks later, the rats were sacrificed, and their retinas, brains, and optic nerves were collected. From the first to second week, FG displayed a greater number of labeled RGCs and a larger diffusion area in the SC than CTB; The number of CTB labeled RGCs and the diffusion area of CTB in the SC increased significantly, but there was no distinction between FG; Furthermore, CTB exhibited more labeled RGC neurites and longer neurites than FG, but no difference was evident between the same trace; The optic nerves labeled using CTB were much clearer than those labeled using FG. In conclusion, both CTB and FG can be used for the retrograde labeling of RGCs in rats at 1 or 2 weeks. FG achieves retrograde labeling of a greater number of RGCs than CTB, whereas CTB better delineates the morphology of RGCs. Furthermore, CTB seems more suitable for retrograde labeling of some small, non-image forming nuclei in the brain to which certain RGC subtypes project their axons.

Highlights

  • Retinal ganglion cells (RGCs) are the main projecting retinal neurons in the visual pathway

  • All groups exhibited detectable staining after tracer injection, but the MD-retinal ganglion cells (RGCs) differed significantly between the Cholera toxin subunit B (CTB) and FG Groups

  • ΔΔTwo-way analysis of variance (ANOVA), p

Read more

Summary

Introduction

Retinal ganglion cells (RGCs) are the main projecting retinal neurons in the visual pathway. They project their axons directly to the brain to perform image-forming and non-image forming functions, and they are the only afferent neurons from the retina [1,2,3,4]. Numerous studies have demonstrated that diseases such as glaucomatous optic neuropathy [5,6,7], traumatic optic neuropathy [8,9,10], ischemic optic neuropathy [11,12,13], and retinal degeneration [14, 15] can lead directly or indirectly to RGC dysfunction or loss. Techniques for evaluating RGC loss and dysfunction have been reviewed by Mead and Tomarev [19]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call